383 related articles for article (PubMed ID: 19783956)
21. Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery.
Mainardes RM; Urban MC; Cinto PO; Chaud MV; Evangelista RC; Gremião MP
Curr Drug Deliv; 2006 Jul; 3(3):275-85. PubMed ID: 16848729
[TBL] [Abstract][Full Text] [Related]
22. Challenges in nasal drug absorption: how far have we come?
Agu RU
Ther Deliv; 2016 Jul; 7(7):495-510. PubMed ID: 27403632
[TBL] [Abstract][Full Text] [Related]
23. From nose to brain: understanding transport capacity and transport rate of drugs.
Wu H; Hu K; Jiang X
Expert Opin Drug Deliv; 2008 Oct; 5(10):1159-68. PubMed ID: 18817519
[TBL] [Abstract][Full Text] [Related]
24. The application of mucoadhesive polymers in nasal drug delivery.
Jiang L; Gao L; Wang X; Tang L; Ma J
Drug Dev Ind Pharm; 2010 Mar; 36(3):323-36. PubMed ID: 19735210
[TBL] [Abstract][Full Text] [Related]
25. Potential of nanoparticulate drug delivery systems by intranasal administration.
Ali J; Ali M; Baboota S; Sahani JK; Ramassamy C; Dao L; Bhavna
Curr Pharm Des; 2010 May; 16(14):1644-53. PubMed ID: 20210751
[TBL] [Abstract][Full Text] [Related]
26. Factors affecting nasal drug delivery and design strategies for intranasal drug delivery.
Hu X; Yue X; Wu C; Zhang X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):328-337. PubMed ID: 37476944
[TBL] [Abstract][Full Text] [Related]
27. Nasal drug delivery in humans.
Bitter C; Suter-Zimmermann K; Surber C
Curr Probl Dermatol; 2011; 40():20-35. PubMed ID: 21325837
[TBL] [Abstract][Full Text] [Related]
28. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
[TBL] [Abstract][Full Text] [Related]
29. A new nanovesicular system for nasal drug administration.
Touitou E; Duchi S; Natsheh H
Int J Pharm; 2020 Apr; 580():119243. PubMed ID: 32209370
[TBL] [Abstract][Full Text] [Related]
30. Quantitative Estimation of the Effect of Nasal Mucociliary Function on in Vivo Absorption of Norfloxacin after Intranasal Administration to Rats.
Inoue D; Kimura S; Kiriyama A; Katsumi H; Yamamoto A; Ogawara KI; Higaki K; Tanaka A; Yutani R; Sakane T; Furubayashi T
Mol Pharm; 2018 Oct; 15(10):4462-4469. PubMed ID: 30165013
[TBL] [Abstract][Full Text] [Related]
31. In situ gel-forming system: an attractive alternative for nasal drug delivery.
Wang X; Liu G; Ma J; Guo S; Gao L; Jia Y; Li X; Zhang Q
Crit Rev Ther Drug Carrier Syst; 2013; 30(5):411-34. PubMed ID: 24099327
[TBL] [Abstract][Full Text] [Related]
32. In situ nasal gel drug delivery: A novel approach for brain targeting through the mucosal membrane.
Kaur P; Garg T; Rath G; Goyal AK
Artif Cells Nanomed Biotechnol; 2016 Jun; 44(4):1167-76. PubMed ID: 25749276
[TBL] [Abstract][Full Text] [Related]
33. Nanomedicines for intranasal delivery: understanding the nano-bio interactions at the nasal mucus-mucosal barrier.
Hua T; Li S; Han B
Expert Opin Drug Deliv; 2024 Apr; 21(4):553-572. PubMed ID: 38720439
[TBL] [Abstract][Full Text] [Related]
34. Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery.
Kumar NN; Gautam M; Lochhead JJ; Wolak DJ; Ithapu V; Singh V; Thorne RG
Sci Rep; 2016 Aug; 6():31732. PubMed ID: 27558973
[TBL] [Abstract][Full Text] [Related]
35. Dehydration affects drug transport over nasal mucosa.
Ali A; Wahlgren M; Rembratt-Svensson B; Daftani A; Falkman P; Wollmer P; Engblom J
Drug Deliv; 2019 Dec; 26(1):831-840. PubMed ID: 31401887
[TBL] [Abstract][Full Text] [Related]
36. Intravail: highly effective intranasal delivery of peptide and protein drugs.
Maggio ET
Expert Opin Drug Deliv; 2006 Jul; 3(4):529-39. PubMed ID: 16822227
[TBL] [Abstract][Full Text] [Related]
37. Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration.
Kadakia E; Bottino D; Amiji M
Pharm Res; 2019 Mar; 36(5):75. PubMed ID: 30923914
[TBL] [Abstract][Full Text] [Related]
38. Physicochemical and physiological considerations for efficient nose-to-brain targeting.
Bahadur S; Pathak K
Expert Opin Drug Deliv; 2012 Jan; 9(1):19-31. PubMed ID: 22171740
[TBL] [Abstract][Full Text] [Related]
39. Development and application of an ex vivo fosphenytoin nasal bioconversion/permeability evaluation method.
Antunes Viegas D; Rodrigues M; Francisco J; Falcão A; Alves G; Santos AO
Eur J Pharm Sci; 2016 Jun; 89():61-72. PubMed ID: 27106504
[TBL] [Abstract][Full Text] [Related]
40. Nasal formulations for drug administration and characterization of nasal preparations in drug delivery.
Scherließ R
Ther Deliv; 2020 Mar; 11(3):183-191. PubMed ID: 32046624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
